PT Kalbe Farma Tbk.
PTKFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $70,611,196 | $72,990,824 | $123,083,504 | $75,275,023 |
| - Cash | $4,723,294 | $3,232,421 | $3,949,769 | $6,216,248 |
| + Debt | $559,222 | $618,538 | $1,167,718 | $626,155 |
| Enterprise Value | $66,447,124 | $70,376,942 | $120,301,453 | $69,684,931 |
| Revenue | $32,627,776 | $30,449,134 | $28,933,503 | $26,261,195 |
| % Growth | 7.2% | 5.2% | 10.2% | – |
| Gross Profit | $12,957,040 | $11,551,489 | $11,704,066 | $11,283,784 |
| % Margin | 39.7% | 37.9% | 40.5% | 43% |
| EBITDA | $4,614,037 | $4,432,826 | $5,246,055 | $4,874,459 |
| % Margin | 14.1% | 14.6% | 18.1% | 18.6% |
| Net Income | $3,240,637 | $2,766,748 | $3,382,210 | $3,183,621 |
| % Margin | 9.9% | 9.1% | 11.7% | 12.1% |
| EPS Diluted | 70.22 | 59.81 | 72.71 | 67.92 |
| % Growth | 17.4% | -17.7% | 7.1% | – |
| Operating Cash Flow | $4,785,179 | $2,907,475 | $3,769,450 | $2,825,946 |
| Capital Expenditures | -$1,250,335 | -$1,178,972 | -$870,100 | -$1,000,870 |
| Free Cash Flow | $3,534,844 | $1,728,503 | $2,899,350 | $1,825,077 |